Patent ID: 11951147
Assignee: MEDIVIR AB
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A  C

Claim 6:
7. The method of claim 1, wherein the cancer is adrenocortical carcinoma, anal cancer, astrocytoma, bladder cancer, bone cancer, breast cancer, cervical cancer, colon cancer, endocrine cancer, endometrial cancer, ependymoma, esophageal cancer, Ewing's sarcoma, extrahepatic bile duct cancer, gallbladder cancer, gastric cancer, glioblastoma, glioma, head and neck cancer, Hodgkin lymphoma, hypopharyngeal cancer, intraocular melanoma, islet cell carcinoma, Kaposi sarcoma, laryngeal cancer, leukemia, lip cancer, liver cancer, lung adenocarcinoma, medulloblastoma, melanoma, meningioma, Merkel cell carcinoma, mesothelioma, multiple myeloma, nasopharyngeal cancer, neuroblastoma, non-Hodgkin lymphoma, non-small cell lung cancer, oral cavity cancer, oropharyngeal cancer, ovarian cancer, pancreatic cancer, paranasal sinus cancer, parathyroid cancer, penile cancer, peripheral neuroma, pheochromocytoma, pineoblastoma, pituitary tumors, prostate cancer, rectal cancer, renal cell cancer, retinoblastoma, rhabdomyosarcoma, salivary gland cancer, skin cancer, small cell lung cancer, small intestine cancer, soft tissue sarcoma, testicular cancer, thymic carcinoma, thymoma, thyroid cancer, urethral cancer, uterine sarcoma, vaginal cancer, vulvar cancer, or Wilm's tumor.